drugset / Trial / NCT00002354

A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients

NCT00002354 ↗

Completed 540 enrolled Merck Sharp & Dohme LLC
Double-blindTreatment

Summary

The purpose of this study is to see if it is safe and effective to give indinavir sulfate plus stavudine to HIV-infected patients who have already been treated with zidovudine.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject INDINAVIR ANHYDROUS Other / unclassified — —
Subject Stavudine Other / unclassified — —